INSIGHTS+ Insights+: The US FDA New Drug Approvals in January 2023BySenior EditorFebruary 15, 20230Comments
VIEWPOINTS Whitney Stewart, Director of Clinical Project Management at Curebase Shares Insights from the Release of a Publication with Digital Therapeutics AllianceBySenior EditorFebruary 14, 20230Comments
VIEWPOINTS Nicolas Paquette-Lamontagne, VP, Medical Affairs at Blueprint Medicines Shares his Views on Clinical Data of Ayvakit for Patients with Systemic MastocytosisBySenior EditorFebruary 13, 20230Comments
INSIGHTS+ Disease of the Month: Age-Related Macular DegenerationBySenior EditorFebruary 9, 20230Comments
VIEWPOINTS Dr. Philip M. Toleikis, President & CEO at Sernova Shares Insights on the Partnership with Evotec to Develop a ‘Functional Cure’ for DiabetesBySenior EditorFebruary 7, 20230Comments
VIEWPOINTS Toni R. Hofhine, President of ATCOR Medical (CardieX) Shares Insights from Pulse- a New at-home Heart Health MonitorBySenior EditorFebruary 6, 20230Comments
VIEWPOINTS John Gabrielson SVP, Biosimilars & Head of Business of Similis Bio (JSR Life Sciences) Shares Insights on the Partnership with Blau Farmaceutica to Co-Develop Four Biosimilar ProgramsBySenior EditorFebruary 2, 20230Comments
